Standard BioTools

Products from companies including Olink, Standard BioTools, Seer, and Biognosys went head-to-head in a study run by Grifols subsidiary Alkahest.

Pro forma revenues, including revenues from SomaLogic, which the firm acquired last January, were also down 9 percent.

Highlights from the fourth day included Geneoscopy's plans to increase access to its ColoSense colorectal cancer screening test through its partnership with Labcorp.